Morphine Extended-Release Capsules and Xopenex Inhalation Solution Concentrate
Determining the interaction of Morphine Extended-Release Capsules and Xopenex Inhalation Solution Concentrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
Generic Name: levalbuterol
Brand name: Xopenex, Xopenex Concentrate, Xopenex HFA
Synonyms: Xopenex Concentrate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Morphine Extended-Release Capsules-Xopenex Pediatric
- Morphine Extended-Release Capsules-Xospata
- Morphine Extended-Release Capsules-Xoten-C
- Morphine Extended-Release Capsules-Xpect-AT
- Morphine Extended-Release Capsules-Xpect-PE
- Morphine Extended-Release Capsules-Xpovio
- Xopenex Inhalation Solution Concentrate-Morphine Immediate-Release Tablets and Capsules
- Xopenex Inhalation Solution Concentrate-Morphine injection
- Xopenex Inhalation Solution Concentrate-Morphine Injection PF
- Xopenex Inhalation Solution Concentrate-Morphine Long-Acting Tablets
- Xopenex Inhalation Solution Concentrate-Morphine Oral Concentrate (20 mg/mL)
- Xopenex Inhalation Solution Concentrate-Morphine Oral Solution